672 related articles for article (PubMed ID: 22913238)
1. [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group].
Adam Z; Szturz P; Pour L; Krejčí M; Zahradová L; Tomíška M; Král Z; Koukalová R; Rehák Z; Mayer J
Vnitr Lek; 2012 Jun; 58(6):455-65. PubMed ID: 22913238
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of Langerhans cells histiocytosis by cladribin reached long-term complete remission in 9 out of 10 adult patients].
Adam Z; Szturz P; Duraš J; Pour L; Krejčí M; Rehák Z; Koukalová R; Navrátil M; Hájek R; Král Z; Mayer J
Klin Onkol; 2012; 25(4):255-61. PubMed ID: 22920165
[TBL] [Abstract][Full Text] [Related]
3. Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven cases.
Adam Z; Szturz P; Vaníček J; Moulis M; Pour L; Krejčí M; Hájek R; Mayer J
Acta Oncol; 2013 Jun; 52(5):994-1001. PubMed ID: 22937955
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
[TBL] [Abstract][Full Text] [Related]
5. Langerhans cell histiocytosis and juvenile xanthogranuloma. Two case reports.
Patrizi A; Neri I; Bianchi F; Guerrini V; Misciali C; Paone G; Burnelli R
Dermatology; 2004; 209(1):57-61. PubMed ID: 15237270
[TBL] [Abstract][Full Text] [Related]
6. Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease.
Simko SJ; Tran HD; Jones J; Bilgi M; Beaupin LK; Coulter D; Garrington T; McCavit TL; Moore C; Rivera-Ortegón F; Shaffer L; Stork L; Turcotte L; Welsh EC; Hicks MJ; McClain KL; Allen CE
Pediatr Blood Cancer; 2014 Mar; 61(3):479-87. PubMed ID: 24106153
[TBL] [Abstract][Full Text] [Related]
7. [Histiocytic diseases in childhood and adolescence].
Vokuhl C; Oschlies I; Klapper W; Leuschner I
Pathologe; 2015 Sep; 36(5):443-50. PubMed ID: 26292932
[TBL] [Abstract][Full Text] [Related]
8. Non-Langerhans cell histiocytosis with isolated CNS involvement: an unusual variant of Erdheim-Chester disease.
Conley A; Manjila S; Guan H; Guthikonda M; Kupsky WJ; Mittal S
Neuropathology; 2010 Dec; 30(6):634-47. PubMed ID: 20337948
[TBL] [Abstract][Full Text] [Related]
9. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease.
Haroche J; Abla O
Hematology Am Soc Hematol Educ Program; 2015; 2015():571-8. PubMed ID: 26637774
[TBL] [Abstract][Full Text] [Related]
10. Histiocytic Diseases of Neonates: Langerhans Cell Histiocytosis, Rosai-Dorfman Disease, and Juvenile Xanthogranuloma.
McClain KL
Clin Perinatol; 2021 Mar; 48(1):167-179. PubMed ID: 33583503
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological evaluation of cladribine treatment response in a case series of patients with xanthoma disseminatum.
Zhou EY; Yu F; Wang Y; Bi Y; Tuan H; Huang Y; Wang B; Li J; Yin H; Li L; Zhao Y
Eur J Dermatol; 2023 Jun; 33(3):270-279. PubMed ID: 37594335
[TBL] [Abstract][Full Text] [Related]
12. Langerhans cell histiocytosis with central nervous system involvement--complete response to 2-chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinib.
Baumann M; Cerny T; Sommacal A; Koeberle D
Hematol Oncol; 2012 Jun; 30(2):101-4. PubMed ID: 21732400
[TBL] [Abstract][Full Text] [Related]
13. Xanthoma disseminatum: effective therapy with 2-chlorodeoxyadenosine in a case series.
Khezri F; Gibson LE; Tefferi A
Arch Dermatol; 2011 Apr; 147(4):459-64. PubMed ID: 21173305
[TBL] [Abstract][Full Text] [Related]
14. [PET-CT documented complete remission of Erdheim-Chester disease, lasting more than 4 years from treatment initiation with cladribine].
Adam Z; Řehák Z; Koukalová R; Bortlíček Z; Krejčí M; Pour L; Szturz P; Prášek J; Nebeský T; Adamová Z; Král Z; Mayer J
Vnitr Lek; 2014; 60(5-6):499, 501-11. PubMed ID: 24974755
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis.
Grobost V; Khouatra C; Lazor R; Cordier JF; Cottin V
Orphanet J Rare Dis; 2014 Nov; 9():191. PubMed ID: 25433492
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system juvenile xanthogranuloma after langerhans cell histiocytosis.
Abla O; Halliday W; Laughlin S; Weitzman S
Pediatr Blood Cancer; 2013 Feb; 60(2):342-3. PubMed ID: 23109301
[No Abstract] [Full Text] [Related]
17. Congenital histiocytosis. A heterogeneous group of diseases, one presenting as so-called congenital self-healing histiocytosis.
Kodet R; Elleder M; De Wolf-Peeters C; Mottl H
Pathol Res Pract; 1991 May; 187(4):458-66. PubMed ID: 1908575
[TBL] [Abstract][Full Text] [Related]
18. The histopathology of Langerhans cell histiocytosis.
Favara BE; Jaffe R
Br J Cancer Suppl; 1994 Sep; 23():S17-23. PubMed ID: 7521200
[TBL] [Abstract][Full Text] [Related]
19. Spumous histiocytic oligoarthritis coexisting with systemic Langerhans' cell histiocytosis: case report and literature review.
Aouba A; Larousserie F; Le Guern V; Martin A; Guillevin L
Joint Bone Spine; 2009 Dec; 76(6):701-4. PubMed ID: 19640768
[TBL] [Abstract][Full Text] [Related]
20. [Cladribine treatment of repeatedly-relapsed Langerhans cell histiocytosis: a case report and literature review].
Yao X; Ying H; Weihong Z; Qing S; Xintian L
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):296-9. PubMed ID: 26182506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
